The Global Diacetylacyclovir Market was valued at USD 37.4 Million in 2024 and is projected to reach USD 58.2 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period (2024-2032). This growth is driven by increasing demand for antiviral medications, particularly acyclovir and valacyclovir derivatives, and advancements in pharmaceutical manufacturing processes across key markets.

As the pharmaceutical industry expands its antiviral drug portfolios to combat global health challenges, demand for high-purity intermediates like diacetylacyclovir continues to rise. This blog profiles the Top 10 Companies in the Diacetylacyclovir Market—innovative manufacturers and suppliers that are securing critical supply chains for antiviral drug production worldwide.

🔟 1. Zhejiang Oma Pharmaceuticals

Headquarters: Zhejiang, China
Key Offering: Purity ≥99% Diacetylacyclovir

Zhejiang Oma Pharmaceuticals leads the global diacetylacyclovir market with vertically integrated production capabilities. The company specializes in high-purity pharmaceutical intermediates, supplying major antiviral drug manufacturers across Asia and Europe.

Quality Certifications:

• GMP and ISO 9001 certified facilities
• FDA-compliant manufacturing processes
• 70%+ market share in Chinese diacetylacyclovir production

Download FREE Sample Report:
Diacetylacyclovir Market – View in Detailed Research Report

9️⃣ 2. Hongyuan Pharmaceuticals